March 11, 2026
VIDO – Six years later: How VIDO helped respond to the COVID-19 pandemic
Member Press Releases
Read More
March 10, 2026
Statement on biomedical countermeasures initiative
Statements & Submissions
Read More
March 9, 2026
Genomics Delegation to Boston – June 2026
Member Press Releases
Read More
March 6, 2026
Canada and CSL Seqirus – a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract
Member Press Releases
Read More
March 2, 2026
Alnylam Canada ULC – Receives Positive Recommendation From Canada’s Drug Agency (CDA) for the Public Reimbursement of AMVUTTRA® (vutrisiran injection), the First and Only RNAi Therapeutic for the Treatment of Cardiomyopathy in Adult Patients with ATTR Amyloidosis
Member Press Releases
Read More
February 25, 2026
35Pharma – to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)
Member Press Releases
Read More
February 23, 2026
BIOTECanada responds to the CDA-AMC`s Consultation on Proposed Enhancements to Drug Reimbursement Reviews
Statements & Submissions
Read More
February 17, 2026
BIOTECanada welcomes the  launch of Canada’s Defence Industrial Strategy
Statements & Submissions
Read More
February 10, 2026
Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. – announce the successful delivery of a seasonal influenza vaccine in development
Member Press Releases
Read More
January 20, 2026
Aspect Biosystems and Novo Nordisk – Enter new phase of partnership to develop curative medicines for diabetes
Member Press Releases
Read More
January 15, 2026
Eyam Health and iiDiagnostics – Launch Pioneering UK-Canada Collaboration to Advance Next-Generation Vaccine Development
Member Press Releases
Read More
December 16, 2025
VIDO – Five ways our research strengthened animal health in 2025
Member Press Releases
Read More
December 11, 2025
Neurenati Therapeutics Inc – Welcomes Dr Daniel Guay to Its Board of Directors and Dr Carlo Di Lorenzo to Its Scientific and Clinical Advisory Board
Member Press Releases
Read More
December 10, 2025
Ventus Therapeutics – Announces First Patient Dosed in Phase 2 Clinical Trial of VENT-03, a Novel Small Molecule cGAS Inhibitor, in Patients with Lupus
Member Press Releases
Read More
December 10, 2025
Medicenna Therapeutics Corp – Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors
Member Press Releases
Read More
December 8, 2025
SWCC (Science Writers) – Global Biotech Week: Uniting science, innovation and community
Media Mentions
Read More
December 3, 2025
BIOTECanada welcomes the launch of CanReview
Statements & Submissions
Read More
December 1, 2025
Morphocell Technologies Inc – Completes US$50 Million Series A Financing
Member Press Releases
Read More
1 2 3 4 5 … 12